- Home
- Profiles
Video Visit Available
Accepting New PatientsPeter D Gorevic, MD
Mount Sinai Doctors Long Island
631-628-5000
- About Me
- Video
- Education & Certifications
- Awards
- Research
- Locations
- Insurance
- Publications
- Patient Experience Rating
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Video
Education
MD, New York University
Residency , Internal Medicine
University of Chicago Hospitals
Residency , Internal Medicine
Bellevue Hospital Center
Residency , Internal Medicine
New York University Medical Center
Residency , Internal Medicine
New York University School of Medicine
Fellowship, Rheumatology
New York University Medical Center
Fellowship, Allergy & Immunology
New York University Medical Center
Certifications
Clinical & Laboratory Immunology
American Board of Allergy & Immunology
Rheumatology
American Board of Internal Medicine
Awards
2009
Best Doctors
New York Magazine
Research
Peter Gorevic is Professor of Medicine of Chief of the Division of Rheumatology. In ongoing studies, he is examining the pathogenesis of the various forms of amyloid disease, with emphasis on those that are concomitant with the aging process in man, including Alzheimer's disease, and articular amyloid often associated with osteoarthritis. Other studies focus on Dialysis Amyloidosis, a major cause of arthropathy and spondyloarthropathy in patients maintained by long-term dialysis. A variety of agents have been proposed to be generic therapeutics for the treatment of the amyloid diseases, including small peptides corresponding to the subsequences of amyloidogenic proteins, monoclonal antibodies, and compounds that interfere with binding to relevant confactors. A transgenic animal model for dialysis amyloidosis, and an in vitro model for cerebrovascular amyloid are under development, each of which will be used for the development of novel diagnostics and to test therapeutics. Other ongoing studies focus on the autoimmune phenomena and clinical deseases that are extrahepatic manifestations of hepatitis C Virus (HCU), and the potential use of this virus to provoke lymphoproliferative diseases such as non-Hodgkin's lymphoma. In particular, the localization of HCU to cryoprecipitable immune complexes is being examined, as well as the effect of biological such as interferon alpha in inhibitig viral replication and B cell proliferation. These studies are funded by NIH-NIDDK, NIH-NINDS, and the Alzheimer's Association.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Patient Experience Rating
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai physician communicated with them during an office visit. The Star Rating is based on patient responses to three questions on the Clinician & Group CAHPS (CG-CAHPS) Survey, a standardized questionnaire developed by Medicare. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Explains in a way you understand
4.8 out of 5
Listens carefully
4.9 out of 5
Likelihood to recommend
4.7 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Gorevic during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Best Doctors
- Gerson Lehrman Group
- Burns White LLC
- Guidepoint Global, LLC.
- Lazard Freres & Co
- ClearView Healthcare Partners
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Brookhaven Memorial Hospital
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- UpToDate Inc./Wolters Kluwer Health
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.